Creasy, Caretha L.
GlaxoSmithKline (United States)
2 papers on CoChatORCID 0000-0002-3735-6401
Most cited papers
- Verified
EZH2 inhibition as a therapeutic strategy for lymphoma with EZH2-activating mutations
McCabe, M. T., Ott, H. M., Ganji, G., Korenchuk, S., Thompson, C., Van Aller, G. S., Liu, Y., Graves, A. P., III, A. D. P., Diaz, E., et al. (2012) · Nature
Epigenetics and DNA MethylationCancer-related gene regulation
Cited by 1,786
- Verified
Epigenomic alterations define lethal CIMP-positive ependymomas of infancy
Mack, S. C., Witt, H., Piro, R. M., Gu, L., Zuyderduyn, S., Stütz, A. M., Wang, X., Gallo, M., Garzia, L., Zayne, K., et al. (2014) · Nature
Glioma Diagnosis and TreatmentEpigenetics and DNA Methylation
Cited by 607
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free